Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2010 by Chinese Academy of Medical Sciences
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Chinese Academy of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01126138
First received: May 18, 2010
Last updated: May 3, 2011
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Publications: